Evidence map›Paper›PMID 40548058›Full record

SynthesisFrontiers in pharmacology2025

Bibliometric analysis of NMDA receptors: 2015-2024.

Yunsheng Liu, Yanyan Jia, Zengwei Kou

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yunsheng LiuCancer Center, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, China.
Yanyan JiaENT Institute and Otorhinolaryngology Department of Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.
Zengwei KouDepartment of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NMDA receptors, a subtype of ionotropic glutamate receptors, play pivotal roles in the brain by mediating synaptic signal transduction, facilitating intercellular communication, and shaping neural circuits, thereby serving as molecular switches for learning and memory. Since its discovery and isolation in the 1960s, NMDA receptors have remained a focal point of research in neuroscience. The past decade has witnessed a large number of high-quality studies on the biophysical properties, three-dimensional structure, and pathophysiological functions of NMDA receptors. In this study, we employed bibliometric methods to analyze publications from 2015 to 2024, visualizing research hotspots, trends, and key milestones of NMDA receptors. Additionally, we also identified the leading researchers, institutions, and countries that contributed to this area. Our findings provide a comprehensive overview of recent NMDA receptor research, which will help readers understand the trends and influence in this field.

Indexed as

bibliometric studybraincitespaceglutamate receptorVOSviewer

Identifiers

PMID40548058
PMCPMC12179074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.